Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma.

MLA

Cohen, Martin H., et al. “Approval Summary: Nelarabine for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 12, no. 18, Sept. 2006, pp. 5329–35. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-06-0606.

APA

Cohen, M. H., Johnson, J. R., Massie, T., Sridhara, R., McGuinn, W. D., Jr, Abraham, S., Booth, B. P., Goheer, M. A., Morse, D., Chen, X. H., Chidambaram, N., Kenna, L., Gobburu, J. V., Justice, R., & Pazdur, R. (2006). Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 12(18), 5329–5335. https://doi.org/10.1158/1078-0432.CCR-06-0606

Chicago

Cohen, Martin H, John R Johnson, Tristan Massie, Rajeshwari Sridhara, W David McGuinn Jr, Sophia Abraham, Brian P Booth, et al. 2006. “Approval Summary: Nelarabine for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 12 (18): 5329–35. doi:10.1158/1078-0432.CCR-06-0606.